Tags |
|
|
Links |
|
|
Others - Expected Drop in UK Insolvencies
According to accounting firm PricewaterhouseCoopers, the number of people in the UK entering into individual voluntary arrangements to
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
escape debt is on the decline. The firm reviews about 50 per cent of all proposed IVAs for its clients who are the creditors of those
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
in debt. Some of these clients include banks. The records of PricewaterhouseCoopers seem to suggest that the trend has been occurring
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
during the past four months.
An IVA is an alternative to filing bankruptcy , and allows the debtor to repay a portion of his or her
An IVA is an alternative to filing bankruptcy , and allows the debtor to repay a portion of his or her
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
debt. An insolvency expert at PwC feels that current trends are indicative of a gradual month to month decrease in IVA cases. One reas
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
on for this is believed to be stabilization in the amount of personal debt after a large increase during the first five years of the 2
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
1st century.
Personal debt increased in 2006, but the amount of outstanding balances on credit cards declined because of a decrease i
Personal debt increased in 2006, but the amount of outstanding balances on credit cards declined because of a decrease i
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
n use, the first time that has happened since their introduction in 1966. Official statistics from the government's Insolvency Service
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
indicated that in 2006, there was nearly a 60 per cent increase in personal insolvencies, but this is believed to be because more peo
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ple turned to IVAs in order to eliminate some of their debts. The figures seem to be stabilizing now that the majority of consumers ha
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ve completed their proposals for IVAs.
Another contributing factor to the decrease in IVAs is the attitude of some lenders that are a
Another contributing factor to the decrease in IVAs is the attitude of some lenders that are a
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
dopting a stricter policy toward the IVA proposals that they receive on behalf of their indebted customers. IVAs are voluntary, and a
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
creditor is not obliged to accept the proposal if he thinks the debtor can repay more of their debts that suggested in the IVA proposa
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
l. Banks are expressing irritations with a minority of people who try to push through IVAs who the lender feels is in a position to pa
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
y off more of their debts without an Individual Voluntary Arrangement.
Research shows that the typical seeker of an IVA is a male in
Research shows that the typical seeker of an IVA is a male in
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
his 40s with debts between ?40,000 and ?43,000. An IVA can significantly cut that debt with a five year repayment term. Because of the
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
hard-nosed attitude that lenders have begun to take toward IVA proposals, new IVA companies that have opened in the past few years ar
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
e reporting a decrease in business over recent months. In spite of that, analysts warn that the trend could pick up again, especially
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
if mortgage rates increase. If interest rates on mortgages increase, people are less likely to use their homes to eliminate debt and w
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ill be forced to find other ways for reduced their debt load such as an Individual Voluntary Arrangement, or perhaps worse, bankruptcy
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.others.org.ua/article/99531/others-Expected-Drop-in-UK-Insolvencies.html">Expected Drop in UK Insolvencies</a>
BB link (for phorums):
[url=http://www.others.org.ua/article/99531/others-Expected-Drop-in-UK-Insolvencies.html]Expected Drop in UK Insolvencies[/url]
Related Articles:
Conveyance of Goods by Natural Persons in Russia
Bookmark it:
|